Mannes M, Dopler A, Zolk O, et al. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity. Blood. 2021;137(4):443-455
Blood
.
2024 Apr 25;143(17):1783.
doi: 10.1182/blood.2024024193.
PMID:
38662389
DOI:
10.1182/blood.2024024193
No abstract available
MeSH terms
Complement Activation
Complement C3* / metabolism
Complement C5 / antagonists & inhibitors
Complement C5 / immunology
Humans
Substances
Complement C3
Complement C5